MINNEAPOLIS, June 13, 2018 /PRNewswire/ -- Preceptis Medical,
Inc. today announced the successful closing of its Series B
financing with follow-on funding led by Montesy Helen (HK) Limited.
Preceptis Medical manufactures the Hummingbird® TTS (Tympanostomy
Tube System) that enables alternatives to general anesthesia for
pediatric ear tube placement. This Series B financing will allow
Preceptis to expand its commercial infrastructure, complete its
office study and develop future pipeline services and
technologies. Further, Preceptis' Chinese partners will be
distributing the Hummingbird in mainland China and Hong Kong. Mr. JC Sun
served as the strategic advisor for the overall Series B investment
and international distribution partnership.
Ear tube procedures are the most common pediatric procedure in
the US (1.2M cases per year), but
current surgical instrument limitations require that these
procedures be performed in children using general anesthesia. The
Hummingbird device is the only product that has received FDA
clearance for conscious sedation, providing the pediatric
healthcare community with an alternative to general anesthesia for
ear tube procedures. "Parents and pediatricians are unequivocal in
their affirmation of the need for this technology for their
children and we continue to see positive momentum with our pilot
commercial release. We are also extremely excited to be adding
a strong group of investors that will provide funding as well as
Chinese commercialization expertise," said Steve Anderson, CEO of Preceptis Medical.
About Preceptis Medical, Inc.
Preceptis Medical manufactures pediatric surgical technologies
designed especially for the unique needs of children. Its first
product, the Hummingbird TTS, mitigates parental anxiety by
enabling alternatives to general anesthesia for children's ear tube
procedures and reduces healthcare costs by enabling the procedure
to be performed out of the expensive operating room.
For additional information, log onto the company's website,
www.preceptismedical.com, or www.facebook.com/HummingbirdEars
Contact:
Beth Ring
Beth@preceptismedical.com
763-568-7810
View original content with
multimedia:http://www.prnewswire.com/news-releases/preceptis-medical-announces-closing-of-series-b-financing-300665899.html
SOURCE Preceptis Medical, Inc.